Biologics Supplier for Orthopedic Practices in Denver, CO

How orthopedic accounts qualify a biologics vendor

Orthopedic practices and surgery centers in this region typically route a new biologics vendor through a compliance or purchasing committee before the first order is placed. That review generally covers the supplier's documentation set, its HCT/P processing description, and how lot-level records are maintained for traceability back to the clinic's patient record.

Because product selection touches regulatory posture, most practices ask their medical director or legal counsel to confirm how a given Wharton's jelly or exosome product is classified before it is added to formulary. Precision Biologics provides the underlying documentation for that review; the classification determination itself belongs to the clinic and its counsel.

Setting up an NPI-verified account

Every order is tied to an account opened in the name of a licensed professional or practice, verified against the NPI Registry before the account is activated. A surgery center with multiple locations can register each site separately so that lot traceability stays tied to the correct practice address.

Account setup includes access to a peer-to-peer call focused on reviewing product documentation - certificate of analysis, donor eligibility summary, and lot release record - rather than clinical guidance, which Precision Biologics does not provide.

Cold-chain shipping into the West region

Cryopreserved formats ship overnight on dry ice in validated containers and are held at -80 degrees C prior to dispatch; lyophilized formats are shelf-stable and do not require cryogenic handling in transit. Receiving staff at a Denver practice should plan for a scheduled delivery window and immediate transfer of cryopreserved product to on-site cold storage.

Each shipment carries a unique lot identifier so the clinic can log receipt against the corresponding certificate of analysis and maintain traceability at the patient record level.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.